Skip to content
April 23, 2024

Equity.Guru

Investment information for the new generation

Search

Mind Cure Health

The Bare Naked Ladies made “if I had a million dollars,” famous, as they tunefully explained what they would do with their riches. However, in the post-crisis everything bubble,…
Naturally occurring psychedelic compounds such as DMT in ayahuasca, psilocybin in magic mushrooms, salvinorum A found in the salvia divinorum mint species, mescaline from peyote cacti and the scolpolamine…
The World Health Organization (WHO) has listed depression as a leading cause of disability worldwide and a major contributor to the overall global burden of disease. Unfortunately, traditional treatments…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Mind Cure Health (MCUR.C) announced they have launched the second stage of manufacturing pharmaceutical grade ibogaine to be used in clinical research. MINDCURE will be assessing the quality of…
Mind Cure Health (MCUR.C) announced the development of two proprietary ketamine-enhanced protocols specifically for pain management and another for depression, according to a press release.   Depression is basically…
Mind Cure (MCUR.C), a leader in advanced proprietary technology for psychedelic therapy, has provided updates regarding its financial position, near-term revenue strategy, and a timeline for iSTRYM’s market launch….
Mind Cure Health (MCUR.C) has entered into a partnership and licensing deal with SOMA Breath Inc. “We think it is important to give individuals options in building their mental…
Mind Cure (MCUR.C) has partnered with Lucid Inc. to design custom psychedelic music experiences for the Company’s iSTRYM technology. “We are building first-of-its-kind functionality by pairing AI-driven music scapes…
Mind Cure Health (MCUR.C) started their first stage of manufacturing pharma-grade ibogaine for both preclinical and clinical research today, according to a press release. Ibogaine is a psychoactive compound…